Alimera reports 86% increase in revenue in first quarter

Alimera Sciences reported net revenue of $3.9 million in the first quarter of 2015, an 86% increase from the first quarter of 2014. The increase was primarily attributed to $2.4 million in U.S. sales of Iluvien, according to a press release. GAAP net loss applicable to common stockholders was reported at $9.8 million, or $0.22 per share, in the first quarter compared with $20.8 million, or $0.58 per share, in the first quarter of the previous year.